BioProcess International Article Cell and Gene Therapy Data Management”

Apr 06, 2020

Skyland Analytics and bluebird bio Address Solutions to Complex Challenges"

Posted by

Robert Di Scipio, CEO of Skyland Analytics, and Steve Goodman, head of drug manufacturing at bluebird bio, gave a presentation together at Phacilitate Leaders World Stem Cell Summit 2019 held January 22-25th. The presentation addressed the complex challenges that face cell and gene therapy development and manufacturing and their solutions to those issues. 

As a result of the high level of interest in the topic, both companies were chosen by BioProcess International (BPI) to co-author the following article: Cell and Gene Therapy Data Management: Solutions to Address Complex Challenges

Skyland and bluebird are collaborating to ensure that bluebird has a CFR Part 11 compliant data management system that supports data transparency and analytics throughout its supply chain.

See all Member News